Aims: We aimed to evaluate the long-term safety and efficacy of the STENTYS self-apposing paclitaxel-eluting stent (STENTYS-PES) in bifurcation lesions in routine clinical practice.
Christoph K. Naber1*, MD; Stylianos A. Pyxaras1, MD; Holger Nef2, MD, PhD; Alexander J. IJsselmuiden3, MD, PhD; Carlo Briguori4, MD, PhD; Christian Schlundt5, MD; Joanna Wykrzykowska6, MD, PhD; Franz R. Eberli7, MD, PhD; Helge Möllmann8, MD, PhD; Søren Galatius9, MD, DMSci; Johannes Rieber10, MD; Philippe Commeau11, MD; Robert-Jan van Geuns12, MD, PhD; David Bouchez1. Contilia Heart and Vascular Center, Elisabeth-Krankenhaus, Essen, Germany; 2. Universitätsklinikum Giessen, Giessen, Germany; 3. Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands; 4. Clinica Mediterranea Hospital, Naples, Italy; 5. Universitätsk
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
bifurcationcoronary diseasedisconnectable stentclinical researchkissing balloon inflationself-apposition
Coronary interventionsStents and scaffoldsBifurcation lesionsTools, devices and techniquesTools, devices and techniques
Read next articleVery high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon